These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 24240037)

  • 21. Emergence of VIM-4- and SHV-12-producing Enterobacter cloacae in a neonatal intensive care unit.
    Juhász E; Jánvári L; Tóth A; Damjanova I; Nobilis A; Kristóf K
    Int J Med Microbiol; 2012 Nov; 302(6):257-60. PubMed ID: 22721811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
    Yang JL; Wang JT; Lauderdale TL; Chang SC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):310-6. PubMed ID: 19949754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
    Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MALDI-TOF MS as a Tool To Detect a Nosocomial Outbreak of Extended-Spectrum-β-Lactamase- and ArmA Methyltransferase-Producing Enterobacter cloacae Clinical Isolates in Algeria.
    Khennouchi NC; Loucif L; Boutefnouchet N; Allag H; Rolain JM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6477-83. PubMed ID: 26239991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012.
    Eibach D; Belmar Campos C; Krumkamp R; Al-Emran HM; Dekker D; Boahen KG; Kreuels B; Adu-Sarkodie Y; Aepfelbacher M; Park SE; Panzner U; Marks F; May J
    Int J Med Microbiol; 2016 Jun; 306(4):249-54. PubMed ID: 27222489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.
    Kristo I; Pitiriga V; Poulou A; Zarkotou O; Kimouli M; Pournaras S; Tsakris A
    Int J Antimicrob Agents; 2013 Apr; 41(4):383-7. PubMed ID: 23375981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
    Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
    J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar.
    Naas T; Cuzon G; Robinson AL; Andrianirina Z; Imbert P; Ratsima E; Ranosiarisoa ZN; Nordmann P; Raymond J
    BMC Infect Dis; 2016 Jun; 16():275. PubMed ID: 27287441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of international ESBL CTX-M-15-producing Enterobacter cloacae ST114 clone in animals.
    Haenni M; Saras E; Ponsin C; Dahmen S; Petitjean M; Hocquet D; Madec JY
    J Antimicrob Chemother; 2016 Jun; 71(6):1497-500. PubMed ID: 26850718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and molecular epidemiology of extended spectrum beta-lactamase producing Enterobacter cloacae isolated from a Tunisian hospital.
    Hammami S; Boutiba-Ben Boubaker I; Saidani M; Lakhal E; Ben Hassen A; Kamoun A; Ghozzi R; Slim A; Ben Redjeb S
    Microb Drug Resist; 2012 Feb; 18(1):59-65. PubMed ID: 21823989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
    Mendonça N; Ferreira E; Louro D; ; Caniça M
    Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of plasmid-mediated AmpC beta-lactamases among Enterobacteriaceae in Algiers hospitals.
    Iabadene H; Messai Y; Ammari H; Alouache S; Verdet C; Bakour R; Arlet G
    Int J Antimicrob Agents; 2009 Oct; 34(4):340-2. PubMed ID: 19570655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period.
    Cantón R; Oliver A; Coque TM; Varela Mdel C; Pérez-Díaz JC; Baquero F
    J Clin Microbiol; 2002 Apr; 40(4):1237-43. PubMed ID: 11923338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals.
    Hoffmann H; Stürenburg E; Heesemann J; Roggenkamp A
    Clin Microbiol Infect; 2006 Apr; 12(4):322-30. PubMed ID: 16524408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of IncHI2 plasmids harbouring blaVIM-1, blaCTX-M-9, aac(6')-Ib and qnrA genes in the spread of multiresistant Enterobacter cloacae and Klebsiella pneumoniae strains in different units at Hospital Vall d'Hebron, Barcelona, Spain.
    Coelho A; Piedra-Carrasco N; Bartolomé R; Quintero-Zarate JN; Larrosa N; Cornejo-Sánchez T; Prats G; Garcillán-Barcia MP; de la Cruz F; González-Lopéz JJ
    Int J Antimicrob Agents; 2012 Jun; 39(6):514-7. PubMed ID: 22481058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China.
    Jiang X; Ni Y; Jiang Y; Yuan F; Han L; Li M; Liu H; Yang L; Lu Y
    J Clin Microbiol; 2005 Feb; 43(2):826-31. PubMed ID: 15695687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses.
    Dierikx CM; van Duijkeren E; Schoormans AH; van Essen-Zandbergen A; Veldman K; Kant A; Huijsdens XW; van der Zwaluw K; Wagenaar JA; Mevius DJ
    J Antimicrob Chemother; 2012 Jun; 67(6):1368-74. PubMed ID: 22382469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First report of CTX-M-15 and CTX-M-3 beta-lactamases among clinical isolates of Enterobacteriaceae in Béjaia, Algeria.
    Touati A; Benallaoua S; Forte D; Madoux J; Brasme L; de Champs C
    Int J Antimicrob Agents; 2006 May; 27(5):397-402. PubMed ID: 16621456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmission and characterization of bla
    Du N; Liu S; Niu M; Duan Y; Zhang S; Yao J; Mao J; Chen R; Du Y
    Ann Clin Microbiol Antimicrob; 2017 Aug; 16(1):58. PubMed ID: 28830556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.
    Szabó D; Bonomo RA; Silveira F; Pasculle AW; Baxter C; Linden PK; Hujer AM; Hujer KM; Deeley K; Paterson DL
    J Clin Microbiol; 2005 Oct; 43(10):5058-64. PubMed ID: 16207962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.